Analyst Ratings for Genomic Health Inc. (GHDX)

Updated: 2017-07-28

Genomic Health Inc. (NASDAQ:GHDX) was awarded an average rating of Hold from investment analysts following the stock. A consensus rating of Hold was previously issued for GHDX last month.

3 analysts declared GHDX a buy, 0 issued an overweight rating, 8 issued a hold rating, 1 gave an underweight rating, and 1 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has decreased by 1. During this time, the number of analysts bearish on the stock has increased by 0.

Many analysts weighed in on price targets for GHDX. The highest price target was 40, implying potential capital gains of 23.65 percent. The lowest price target was 27, implying a possible loss of -16.54 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -200 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -25 percent.

Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, while 0 analysts revised their estimates downwards. Over the same time period, 0 analysts revised their FY earnings estimates upwards, while 0 analysts made negative revisions to their fiscal year's estimates.

In the trailing 52-weeks, GHDX hit 33.97 at the highest peak, while it's lowest trading point was 25.66. Currently the stock is 26.07 percent higher than its low, and below the high by 4.77 percent. GHDX has a price/earnings ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The GHDX value stock report compares GHDX to some of its peers using value stock charts. The market cap of GHDX is $1.1 billion. GHDX is estimated to release their earnings results for the quarter on 0000-00-00, days from today.